ÎåÐÇÌåÓýÖ±²¥ to Participate in the H.C. Wainwright Virtual BioConnect Conference
REDWOOD CITY, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- ÎåÐÇÌåÓýÖ±²¥ (Nasdaq:CDXS), a leading protein engineering company, today announced that John Nicols, the Company’s President and Chief Executive officer, will participate in a fireside chat presentation at the H.C. Wainwright BioConnect 2021 Conference, being held virtually January 11-14, 2021.
A replay of the pre-recorded fireside chat will be available beginning Monday, January 11, at 6:00 a.m. ET and will be archived on the Investors section of the Company’s website, . The recording will be available for a period of 30 days following the event.
About ÎåÐÇÌåÓýÖ±²¥
ÎåÐÇÌåÓýÖ±²¥ is a leading protein engineering company that applies its proprietary CodeEvolver® technology to develop proteins for a variety of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, fine chemicals and industrial enzymes, and enzymes as biotherapeutics and for use in molecular diagnostics. ÎåÐÇÌåÓýÖ±²¥â€™ proven technology enables improvements in protein performance, meeting customer needs for rapid, cost-effective and sustainable manufacturing in multiple commercial-scale implementations of biocatalytic processes. More information can be found at .
Forward-Looking Statements
To the extent that statements contained in this press release are not descriptions of historical facts regarding ÎåÐÇÌåÓýÖ±²¥, they are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor of the Private Securities Litigation Reform Act of 1995,. Such forward-looking statements involve substantial risks and uncertainties that could cause ÎåÐÇÌåÓýÖ±²¥â€™ future results, performance or achievements to differ significantly from those expressed or implied by the forward-looking statements. ÎåÐÇÌåÓýÖ±²¥ undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to ÎåÐÇÌåÓýÖ±²¥â€™ business in general, please refer to ÎåÐÇÌåÓýÖ±²¥â€™ prospectus supplement to be filed with the SEC, including the documents incorporated by reference therein, which include ÎåÐÇÌåÓýÖ±²¥â€™ Annual Report on Form 10-K filed with the SEC on February 28, 2020, ÎåÐÇÌåÓýÖ±²¥â€™ Quarterly Report on Form 10-Q filed with the SEC on November 6, 2020, and ÎåÐÇÌåÓýÖ±²¥â€™ other periodic reports filed with the SEC.
Investor Relations Contact:
Argot Partners
Stephanie Marks/Natallia Clancy
(212)600-1902
ÎåÐÇÌåÓýÖ±²¥@argotpartners.com
Source: ÎåÐÇÌåÓýÖ±²¥
Released January 5, 2021